Fredag 16 Maj | 07:19:19 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2025-10-30 07:30 Kvartalsrapport 2025-Q3
2025-07-10 07:30 Kvartalsrapport 2025-Q2
2025-06-26 N/A Årsstämma
2025-05-23 N/A X-dag ordinarie utdelning QLINEA 0.00 SEK
2025-04-14 - Kvartalsrapport 2025-Q1
2025-04-03 - Extra Bolagsstämma 2025
2025-02-28 - Bokslutskommuniké 2024
2024-11-05 - Kvartalsrapport 2024-Q3
2024-07-11 - Kvartalsrapport 2024-Q2
2024-06-28 - Årsstämma
2024-06-12 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2024-05-31 - Kvartalsrapport 2024-Q1
2024-02-27 - Bokslutskommuniké 2023
2023-11-02 - Kvartalsrapport 2023-Q3
2023-07-13 - Kvartalsrapport 2023-Q2
2023-07-03 - Extra Bolagsstämma 2023
2023-06-13 - Årsstämma
2023-05-24 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2023-05-04 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-07-14 - Kvartalsrapport 2022-Q2
2022-05-25 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2022-05-24 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-04 - Kvartalsrapport 2021-Q3
2021-07-15 - Kvartalsrapport 2021-Q2
2021-05-26 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2021-05-25 - Årsstämma
2021-05-06 - Kvartalsrapport 2021-Q1
2021-02-18 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-07-16 - Kvartalsrapport 2020-Q2
2020-05-27 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2020-05-26 - Årsstämma
2020-05-07 - Kvartalsrapport 2020-Q1
2020-02-13 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-07-18 - Kvartalsrapport 2019-Q2
2019-05-23 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2019-05-22 - Årsstämma
2019-05-03 - Kvartalsrapport 2019-Q1
2019-02-14 - Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Q-Linea är verksamt inom medicinteknik. Bolaget är specialiserat inom forskning och utveckling av instrument och förbrukningsartiklar. Produkterna används huvudsakligen vid behandling av infektionssjukdomar och blodförgiftning, och innefattar diagnostik- och analysverktyg, samt grundläggande provhantering. Tekniken baseras på den så kallade ID- samt AST tekniken. Q-Linea grundades 2008 och har huvudkontor i Uppsala.
2025-05-15 08:25:00

The nomination committee of Q-linea AB (publ) submits the following proposals to be presented at the annual general meeting of shareholders to be held on June 26th, 2025, regarding the number and election of members of the board of directors.

The nomination committee proposes six members of the board of directors and no deputy members of the board of directors.

The nomination committee proposes re-election of Erika Kjellberg Eriksson, Mario Gualano, Karin Fischer and Jonas Jarvius as members of the board of directors, and election of Johan Bygge and Sebastian Backlund for a term of office until the end of the next annual general meeting. Furthermore, the nomination committee proposes election of Johan Bygge as chairman and re-election of Mario Gualano as vice chairman of the board.

Johan Bygge has a solid background in leading and developing prominent global companies, including CFO at Investor, Asia Head of EQT and senior executives at both Electrolux and Husqvarna. He currently sits on several boards, including: Tredje AP-fonden, Getinge AB (publ), Lantmännen ek för, CapMan Oyj, Scandi Standard AB (publ) and Guard Therapeutics International AB (publ). Johan's expertise in building companies for the long term and developing global market-leading companies makes him an optimal choice for chairman of Q-linea given the commercialization phase the company is in.

Sebastian Backlund is employed by Investment AB Öresund as Investment Manager and is expected to contribute to the work of the board and the company with his strong knowledge in financial and commercial analysis, internal structure and process improvement, capital market as well as M&A experience from his previous employers: MedCap AB (publ) and EY Corporate Finance. Sebastian currently sits on the board of Scandi Standard AB and has also served on the board of Multi-Ply Components. With Sebastian as an addition to the board, Q-linea gains access to additional knowledge and experience that are valuable for the journey towards becoming a profitable growth company.

Information about all the members proposed to Q-linea's board, the nomination committee's reasoned statement regarding the proposal to the board and the nomination committee's complete proposal will be available on the company's website, www.qlinea.com in connection with the issue of the notice to the 2025 annual general meeting, which is expected to take place during the week 21.

The nomination committee has been appointed according to the principles decided by the 2024 annual general meeting and consists of Öystein Engebretsen (Investment AB Öresund), chairman of the nomination committee, Erika Kjellberg Eriksson (Nexttobe AB, chairman of the board) and Ulf Landegren (Landegren Gene Technology AB).